Boothbay Fund Management’s Axogen AXGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-17,869
Closed -$319K 1965
2025
Q3
$319K Buy
+17,869
New +$259K ﹤0.01% 1420
2021
Q4
Sell
-17,563
Closed -$277K 1860
2021
Q3
$277K Buy
17,563
+3,115
+22% +$55.9K 0.01% 1372
2021
Q2
$312K Buy
14,448
+2,510
+21% +$50.7K 0.01% 1252
2021
Q1
$242K Sell
11,938
-11,561
-49% -$228K 0.01% 1289
2020
Q4
$421K Buy
+23,499
New +$345K 0.02% 815

Other funds holding AXGN

Boothbay Fund Management's AXGN Position: Q4 2025 in Review

Boothbay Fund Management sold out of Axogen (AXGN) in Q4 2025, closing a stake of 17,869 shares — an estimated $319K sold.

Boothbay Fund Management first reported a position in AXGN in Q4 2020 and held it in 5 quarters. The position peaked at $421K in Q4 2020. 208 funds tracked by Wall St. Rank hold AXGN as of Q4 2025.

  • Boothbay Fund Management reported no remaining Axogen position as of Q4 2025 after selling out during the quarter.
  • Boothbay Fund Management sold 17,869 Axogen shares in Q4 2025, an estimated $319K.
  • Boothbay Fund Management first reported a position in Axogen in Q4 2020 and held it in 5 quarters.
  • Boothbay Fund Management's Axogen position peaked at $421K in Q4 2020.
  • 208 funds tracked by Wall St. Rank held Axogen as of Q4 2025.

Based on Boothbay Fund Management's 13F filing for Q4 2025, filed 17 Feb 2026.